In a recent discussion of thyrotropin (thyroid-stimulating hormone) measurement, Musto et al.
(1) draw attention to the clinical importance of good performance at low concentrations. A thyrotropin assay that has adequate reproducibility throughout the "normal" range and is essentially free of nonspecific matrix effects can be expected to confer two benefits. First, it will minimize the number of borderline results that will require the thyroliberin (thyrotropin-releasing factor, TRF) test as followup. Second, it will provide more meaningful baseline values for comparison with values obtained after TRF stimulation.
The high upper limit of normal that is characteristic of most commercially available thyrotropin assays is symptomatic of their inability to provide precise and accurate measurements of thyrotropin at low concentrations. Clinicians who regularly encounter only results for thyrotropin generated by commercially available kits may well be inclined to doubt this assertion. But the point made by Musto et al. is an important one, and this Note is intended to document its truth.
Studies aimed at determining the reference interval for normal individuals can provide important insights into the acceptability of an assay system. This is especially true of assays for thyrotropin, where an upper limit of normal significantly higher than those reported for fully optimized radioimmunoassays may well be symptomatic of shortcomings that can seriously compromise clinical efficacy (1).
There is, in fact, a striking contrast between most but not all thyrotropin kits now on the market and the several "research" radioimmunoassays (2-6) tabulated in Table 1 . The latter characteristically
show an upper limit of normal of approximately 3 or 4 milli-int. units/L. The stated normal range for most kits, on the other hand, has until recently extended up to 10 milli-int. units/L.
While there has been an encouraging trend towards more accurate thyrotropin kits, an upper limit of 7 milli-int. unitsfL represents, even today, the norm for nearly all commercially available assays. This shows that the great majority of thyrotropin kits still err, on borderline samples, by a factor of two relative to more definitive assay systems. Indeed, it is rare to encounter any thyrotropin procedure with a reasonable assay time (same-day or overnight) that
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Research Assays vs Kit Methods
The systems here designated as "research" assays have strong claims to being regarded as reference methods for thyrotropin.
First, they were established more than a decade ago, and since then have contributed significantly to our understanding of the physiology and clinical relevance of this pituitary hormone. This is reflected not only in countless journal articles but also in standard medical textbooks and reviews, where values ranging from 3.0 to 5.0 milli-int. units/L are usually quoted as the accepted upper limit of normal (1, 5,
9-11).
Second, these research assays resemble the typical thyrotropin kit of today in being nonequilibrium, competitive, double-antibody radioirnmunoassays.
They differ prinulpally in the degree to which they have been optimized for sensitivity and specificity. Comparisons between the research assays and the kit methods are therefore in order.
Characteristically, the research assays involve use of meticulously purified tracer, incubation times of six days or more, and standard curves prepared with human serum. These features can be expected to minimize nonspecific "matrix effects," resulting in lower and more accurate values throughout the normal reference interval (12).
Some of these features appear to be essential for meaningful results, particularly the steps taken to purify the tracer and to eliminate matrix differences between standards and unknowns.
It has been shown repeatedly that neither buffered human serum albumin nor an animal serum matrix is an adequate substitute for a human serum matrix (8, (12) (13) (14) (15) from normal adults and assayed by radioimniunoassay, both before and after suppression by treatment with thyroid hormones, provide evidence that the true median value for circulating thyrotropin is barely 1 milhi-int. unitJL (21).
Clinical Significance
From studies performed with the research assays, a great deal has been learned as a result of optimizing for sensitivity and specificity, thanks to the superior delineation of the normal reference interval that this entails.
Thus, we now know that thyrotropin exhibits a circadian rhythm, with lower values in the morning and higher values near midnight (15, 22). We know more exactly the pattern exhibited by thyrotropin during pregnancy (16, 23 
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